Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

A CS1-NKG2D bispecific antibody collectively activates cytolytic immune cells against multiple myeloma.

Chan WK, Kang S, Youssef Y, Glankler EN, Barrett ER, Carter AM, Ahmed EH, Prasad A, Chen L, Zhang J, Benson DM, Caligiuri MA, Yu J.

Cancer Immunol Res. 2018 May 16. pii: canimm.0649.2017. doi: 10.1158/2326-6066.CIR-17-0649. [Epub ahead of print]

PMID:
29769244
2.

Angiolymphoid hyperplasia with eosinophilia: a case report.

Youssef A, Hasan AR, Youssef Y, Al-Soufi L, Elshimali Y, Alshehabi Z.

J Med Case Rep. 2018 Apr 2;12(1):89. doi: 10.1186/s13256-018-1599-x.

3.

Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience).

Ben Lakhal R, Ghedira H, Bellaaj H, Ben Youssef Y, Menif S, Manai Z, Bedoui M, Lakhal A, M'Sadek F, Elloumi M, Khélif A, Ben Romdhane N, Laatiri MA, Ben Othmen T, Meddeb B.

Ann Hematol. 2018 Apr;97(4):597-604. doi: 10.1007/s00277-017-3224-2. Epub 2018 Jan 6.

PMID:
29305630
4.

Tunisian adult's Hodgkin lymphoma Study Group.

Ben Lakhal R, Hdiji S, Ben Youssef Y, Laariri MA, Zriba S, Toumi N, Mokrani A, Ezzaier F, Ladb S, Frikha H, Mesai T, Ben Salah H, Tebra S, Daoued J, Bouaouina N, Maalej M, Frikha M, Ben Ahmed S, Mezlini A, Ben Othmen T, Msaddek F, Khelif A, Elloumi M, Meddeb B.

Tunis Med. 2016 Nov;94(11):706.

5.

IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB.

Victor AR, Nalin AP, Dong W, McClory S, Wei M, Mao C, Kladney RD, Youssef Y, Chan WK, Briercheck EL, Hughes T, Scoville SD, Pitarresi JR, Chen C, Manz S, Wu LC, Zhang J, Ostrowski MC, Freud AG, Leone GW, Caligiuri MA, Yu J.

J Immunol. 2017 Oct 1;199(7):2333-2342. doi: 10.4049/jimmunol.1601554. Epub 2017 Aug 25.

PMID:
28842466
6.

Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia.

Ben Hassine I, Gharbi H, Soltani I, Ben Hadj Othman H, Farrah A, Amouri H, Teber M, Ghedira H, Ben Youssef Y, Safra I, Abbes S, Menif S.

Cancer Chemother Pharmacol. 2017 Oct;80(4):829-839. doi: 10.1007/s00280-017-3424-4. Epub 2017 Aug 23.

PMID:
28836054
7.

GATA2 gene analysis in several forms of hematological malignancies including familial aggregations.

Hamadou WS, Mani R, Besbes S, Bourdon V, Youssef YB, Eisinger F, Mari V, Gesta P, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Noguchi T, Khélif A, Sobol H, Soua Z.

Ann Hematol. 2017 Oct;96(10):1635-1639. doi: 10.1007/s00277-017-3076-9. Epub 2017 Jul 27.

PMID:
28752392
8.

Novel cellulose-based halochromic test strips for naked-eye detection of alkaline vapors and analytes.

Abou-Yousef H, Khattab TA, Youssef YA, Al-Balakocy N, Kamel S.

Talanta. 2017 Aug 1;170:137-145. doi: 10.1016/j.talanta.2017.04.002. Epub 2017 Apr 6.

PMID:
28501149
9.

Minimal residual disease detection in Tunisian B-acute lymphoblastic leukemia based on immunoglobulin gene rearrangements.

Besbes S, Hamadou WS, Boulland ML, Youssef YB, Achour B, Regaieg H, Khelif A, Fest T, Soua Z.

Braz J Med Biol Res. 2017 Jan 16;50(1):e5426. doi: 10.1590/1414-431X20165426.

10.

ARLTS1, potential candidate gene in familial aggregation of hematological malignancies.

Hamadou WS, Besbes S, Mani R, Bourdon V, Ben Youssef Y, Achour B, Regaieg H, Eisinger F, Mari V, Gesta P, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Noguchi T, Khélif A, Sobol H, Soua Z.

Bull Cancer. 2017 Feb;104(2):123-127. doi: 10.1016/j.bulcan.2016.10.016. Epub 2016 Nov 17.

PMID:
27866680
11.

Familial hematological malignancies: new IDH2 mutation.

Hamadou WS, Bourdon V, Létard S, Brenet F, Laarif S, Besbes S, Paci A, David M, Penard-Lacronique V, Youssef YB, Laatiri MA, Eisinger F, Mari V, Gesta P, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Noguchi T, Khélif A, Salem CB, Dubreuil P, Sobol H, Soua Z.

Ann Hematol. 2016 Dec;95(12):1943-1947. Epub 2016 Sep 3.

PMID:
27591990
12.

[Juvenile myelomonocytic leukemia: A three-case series].

Ghariani I, Jmili-Braham N, Regaieg H, Achour B, Ben Youssef Y, Sendi H, Bakir L, Kortas M.

Arch Pediatr. 2016 Dec;23(12):1264-1269. doi: 10.1016/j.arcped.2016.09.007. Epub 2016 Oct 24. French.

PMID:
27789175
13.

Acute methotrexate neurotoxicity revealed by a cerebellar syndrome.

Zahra K, Bouneb R, Mahjoub M, Zaghouani H, Zaier M, Ben Youssef Y, Khelif A.

Rev Neurol (Paris). 2016 Dec;172(12):791-793. doi: 10.1016/j.neurol.2016.09.005. Epub 2016 Oct 20. No abstract available.

PMID:
27773447
14.

Combined IKZF1 and IG markers as new tools for diagnosis and minimal residual disease assessment in Tunisian B-ALL.

Besbes S, Hamadou WS, Boulland ML, Lefranc MP, Ben Youssef Y, Achour B, Khelif A, Fest T, Soua Z.

Bull Cancer. 2016 Oct;103(10):822-828. doi: 10.1016/j.bulcan.2016.07.008. Epub 2016 Sep 7.

PMID:
27614734
15.

Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia cases.

Hamadou WS, Besbes S, Bourdon V, Youssef YB, Laatiri MA, Noguchi T, Khélif A, Sobol H, Soua Z.

Fam Cancer. 2017 Jan;16(1):153-157. doi: 10.1007/s10689-016-9931-3.

PMID:
27619989
16.

NKp80 Defines a Critical Step during Human Natural Killer Cell Development.

Freud AG, Keller KA, Scoville SD, Mundy-Bosse BL, Cheng S, Youssef Y, Hughes T, Zhang X, Mo X, Porcu P, Baiocchi RA, Yu J, Carson WE 3rd, Caligiuri MA.

Cell Rep. 2016 Jul 12;16(2):379-391. doi: 10.1016/j.celrep.2016.05.095. Epub 2016 Jun 30.

17.

Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies.

Hamadou WS, Bourdon V, Gaildrat P, Besbes S, Fabre A, Youssef YB, Regaieg H, Laatiri MA, Eisinger F, Mari V, Gesta P, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Jemni SY, Noguchi T, Khélif A, Sobol H, Soua Z.

Ann Hematol. 2016 Jun;95(7):1043-50. doi: 10.1007/s00277-016-2678-y. Epub 2016 Apr 23.

PMID:
27106701
18.

Successful Strategies for Practice-Based Recruitment of Racial and Ethnic Minority Pregnant Women in a Randomized Controlled Trial: the IDEAS for a Healthy Baby Study.

Goff SL, Youssef Y, Pekow PS, White KO, Guhn-Knight H, Lagu T, Mazor KM, Lindenauer PK.

J Racial Ethn Health Disparities. 2016 Dec;3(4):731-737. Epub 2016 Apr 11.

19.

Case Report: A Neocystostomy Perforation Presenting as a Gallstone.

Kalra R, Reyad A, Gordon D, Verna D, Youssef Y.

Urol Case Rep. 2015 Jun 6;3(5):146-8. doi: 10.1016/j.eucr.2015.03.007. eCollection 2015 Sep.

20.

Familial hematological malignancies: ASXL1 gene investigation.

Hamadou WS, Abed RE, Besbes S, Bourdon V, Fabre A, Youssef YB, Laatiri MA, Eisinger F, Mari V, Gesta P, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Jemni SY, Noguchi T, Khélif A, Sobol H, Soua Z.

Clin Transl Oncol. 2016 Apr;18(4):385-90. doi: 10.1007/s12094-015-1379-7. Epub 2015 Aug 19.

PMID:
26286068
21.

Preventing Distal Catheter Obstruction in Laparoscopic Ventriculoperitoneal Shunt Placement in Adults: The "Falciform Technique".

Svoboda SM, Park H, Naff N, Dorai Z, Williams MA, Youssef Y.

J Laparoendosc Adv Surg Tech A. 2015 Aug;25(8):642-5. doi: 10.1089/lap.2015.0196. Epub 2015 Jul 17.

PMID:
26186206
22.

Robotic single-site versus laparoscopic cholecystectomy: Which is cheaper? A cost report and analysis.

Bedeir K, Mann A, Youssef Y.

Surg Endosc. 2016 Jan;30(1):267-72. doi: 10.1007/s00464-015-4203-0. Epub 2015 Apr 11.

PMID:
25861905
23.

Hospital environment fungal contamination and aspergillosis risk in acute leukaemia patients in Sousse (Tunisia).

Gheith S, Ranque S, Bannour W, Ben Youssef Y, Khelif A, Ben Said M, Njah M, Saghrouni F.

Mycoses. 2015 Jun;58(6):337-42. doi: 10.1111/myc.12320. Epub 2015 Mar 24.

PMID:
25809008
24.

Robotic single-site cholecystectomy in the obese: outcomes from a single institution.

Svoboda S, Qaqish TR, Wilson A, Park H, Youssef Y.

Surg Obes Relat Dis. 2015 Jul-Aug;11(4):882-5. doi: 10.1016/j.soard.2014.11.016. Epub 2014 Nov 25.

PMID:
25547055
25.

Foley catheter through a colovesical fistula: an unusual method of diagnosis.

Pindoria K, Reyad A, Youssef Y.

BMJ Case Rep. 2014 May 13;2014. pii: bcr2014204968. doi: 10.1136/bcr-2014-204968. No abstract available.

26.

Characteristics of invasive aspergillosis in neutropenic haematology patients (Sousse, Tunisia).

Gheith S, Saghrouni F, Bannour W, Ben Youssef Y, Khelif A, Normand AC, Ben Said M, Piarroux R, Njah M, Ranque S.

Mycopathologia. 2014 Jun;177(5-6):281-9. doi: 10.1007/s11046-014-9742-8. Epub 2014 Apr 12.

PMID:
24728707
27.

In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia.

Gheith S, Saghrouni F, Bannour W, Ben Youssef Y, Khelif A, Normand AC, Piarroux R, Ben Said M, Njah M, Ranque S.

Springerplus. 2014 Jan 10;3:19. doi: 10.1186/2193-1801-3-19. eCollection 2014.

28.

Laparoscopic assessment in surgical trauma (LAST): a "last" diagnostic step in the trauma bay.

Park H, Youssef Y.

Injury. 2014 May;45(5):918-9. doi: 10.1016/j.injury.2013.11.003. Epub 2013 Nov 13. No abstract available.

PMID:
24287338
29.

Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study.

Amin MA, Sabry D, Rashed LA, Aref WM, el-Ghobary MA, Farhan MS, Fouad HA, Youssef YA.

Clin Transplant. 2013 Jul-Aug;27(4):607-12. doi: 10.1111/ctr.12179.

PMID:
23923970
30.

Multiple myeloma following essential thrombocythemia.

Ben Youssef Y, Gmidène A, Bouabid Z, Bouallegui S, Sriha B, Zaier M, Sennana H, Khelif A.

Ann Biol Clin (Paris). 2013 Jul-Aug;71(4):457-60. doi: 10.1684/abc.2013.0856. Review.

31.

A novel t(3;12)(q21;p13) translocation in a patient with accelerated chronic myeloid leukemia after imatinib and nilotinib therapy.

Bennour A, Tabka I, Ben Youssef Y, Kmeira Z, Khelif A, Saad A, Sennana H.

Cancer Biol Med. 2013 Mar;10(1):47-51. doi: 10.7497/j.issn.2095-3941.2013.01.008.

32.

Differentiation of Fanconi anemia and aplastic anemia using mitomycin C test in Tunisia.

Talmoudi F, Kilani O, Ayed W, Ben Halim N, Mellouli F, Torjmane L, Aissaoui L, Ben Youssef Y, Kammoun L, Ben Othmane T, Bejaoui M, Ben Romdhane N, Elloumi M, Hadiji S, Hentati S, Chemkhi I, Abidli N, Guermani H, Abdelhak S, Amouri A.

C R Biol. 2013 Jan;336(1):29-33. doi: 10.1016/j.crvi.2013.02.001. Epub 2013 Mar 11.

PMID:
23537767
33.

Development of simulator guidelines for resident assessment in flexible endoscopy.

Sutton E, Chase SC, Klein R, Zhu Y, Godinez C, Youssef Y, Park A.

Am Surg. 2013 Jan;79(1):14-22.

PMID:
23317591
34.

A PML/RARA chimeric gene on chromosome 12 in a patient with acute promyelocytic leukemia (M4) associated with a new variant translocation: t(12;15;17)(q24;q24;q11).

Bennour A, Tabka I, Youssef YB, Zaier M, Hizem S, Khelif A, Saad A, Sennana H.

Med Oncol. 2013 Mar;30(1):409. doi: 10.1007/s12032-012-0409-3. Epub 2013 Jan 6.

PMID:
23292868
35.

Utilization of salt whey from Egyptian Ras (cephalotyre) cheese in microbial milk clotting enzymes production.

El-Tanboly el-S, El-Hofi M, Youssef YB, El-Desoki W, Ismail A.

Acta Sci Pol Technol Aliment. 2013 Jan-Mar;12(1):9-20.

PMID:
24584861
36.

Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia.

Bennour A, Ouahchi I, Achour B, Zaier M, Youssef YB, Khelif A, Saad A, Sennana H.

Med Oncol. 2013 Mar;30(1):348. doi: 10.1007/s12032-012-0348-z. Epub 2012 Dec 27.

PMID:
23269583
37.

Chronic myeloid leukemia as a secondary malignancy after lymphoma in a child. A case report and review of the literature.

Zahra K, Ben Fredj W, Ben Youssef Y, Zaghouani H, Chebchoub I, Zaier M, Badreddine S, Braham N, Sennana H, Khelif A.

Onkologie. 2012;35(11):690-3. doi: 10.1159/000343952. Epub 2012 Oct 22. Review.

PMID:
23147546
38.

Nasopharyngeal/nasal type NK/T lymphoma: analysis of 23 cases and current review of the literature.

Youssef YB, Bougmiza I, Bouabid Z, Achour B, Regaieg H, Sriha B, Belkadhi M, Omri HE, Khelif A.

Kulak Burun Bogaz Ihtis Derg. 2012 Sep-Oct;22(5):275-83. doi: 10.5606/kbbihtisas.2012.053. Review.

PMID:
22991988
39.

Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma.

Girgis AH, Iakovlev VV, Beheshti B, Bayani J, Squire JA, Bui A, Mankaruos M, Youssef Y, Khalil B, Khella H, Pasic M, Yousef GM.

Cancer Res. 2012 Oct 15;72(20):5273-84. doi: 10.1158/0008-5472.CAN-12-0656. Epub 2012 Aug 27.

40.

The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.

Faragalla H, Youssef YM, Scorilas A, Khalil B, White NM, Mejia-Guerrero S, Khella H, Jewett MA, Evans A, Lichner Z, Bjarnason G, Sugar L, Attalah MI, Yousef GM.

J Mol Diagn. 2012 Jul;14(4):385-92. doi: 10.1016/j.jmoldx.2012.02.003. Epub 2012 May 9.

PMID:
22580180
41.

Cytogenetic profile of a large cohort of Tunisian de novo acute myeloid leukemia.

Gmidène A, Sennana H, Wahchi I, Youssef YB, Jeddi R, Elloumi M, Saad A.

Hematology. 2012 Jan;17(1):9-14. doi: 10.1179/102453312X13221316477417.

PMID:
22549442
42.

The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer.

White NM, Youssef YM, Fendler A, Stephan C, Jung K, Yousef GM.

Biol Chem. 2012 Apr;393(5):379-89. doi: 10.1515/hsz-2011-0246.

PMID:
22505520
43.

[Creation and report of the Tunisian Fanconi Anemia Registry (TFAR)].

Hadiji Mseddi S, Kammoun L, Bellaaj H, Ben Youssef Y, Aissaoui L, Torjemane L, Telmoudi F, Amouri A, Elghezal H, Ouederni M, Ben Abdennebi Y, Hammemi S, Ben Othmen T, Ben Abid H, Bejaoui M, Abdelhak S, Hachicha M, Dellagi K, Frikha M; le Groupe d’étude tunisien de l’anémie de Fanconi GETAF.

Arch Pediatr. 2012 May;19(5):467-75. doi: 10.1016/j.arcped.2012.02.017. Epub 2012 Apr 4. French.

PMID:
22480464
44.

Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America.

Knight G, Earle CC, Cosby R, Coburn N, Youssef Y, Malthaner R, Wong RK; Gastrointestinal Cancer Disease Site Group.

Gastric Cancer. 2013 Jan;16(1):28-40. doi: 10.1007/s10120-012-0148-3. Epub 2012 Mar 31. Review.

PMID:
22467061
45.

Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.

Petraki C, Youssef YM, Dubinski W, Lichner Z, Scorilas A, Pasic MD, Komborozos V, Khalil B, Streutker C, Diamandis EP, Yousef GM.

Tumour Biol. 2012 Aug;33(4):1209-14. doi: 10.1007/s13277-012-0368-5. Epub 2012 Mar 22.

PMID:
22437349
46.

Comparative study on the efficiency of using pulsed and direct current electrochemotherapy in treating ehrlich tumor.

Shawki MM, Elblbesy MA, Shalaby TE, Qotb MA, Youssef YS.

Int J Biomed Sci. 2012 Mar;8(1):16-21.

47.

Pleiotropic action of renal cell carcinoma-dysregulated miRNAs on hypoxia-related signaling pathways.

Lichner Z, Mejia-Guerrero S, Ignacak M, Krizova A, Bao TT, Girgis AH, Youssef YM, Yousef GM.

Am J Pathol. 2012 Apr;180(4):1675-87. doi: 10.1016/j.ajpath.2011.12.030. Epub 2012 Feb 9.

PMID:
22326755
48.

Geotrichum capitatum septicemia in patients with acute myeloid leukemia. Report of three cases.

Saghrouni F, Abdeljelil JB, Youssef YB, Abdeljelil NB, Gheith S, Fathallah A, Said MB.

Med Mycol Case Rep. 2012 Sep 26;1(1):88-90. doi: 10.1016/j.mmcr.2012.09.003. eCollection 2012.

49.

Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis.

Dubinski W, Gabril M, Iakovlev VV, Scorilas A, Youssef YM, Faragalla H, Kovacs K, Rotondo F, Metias S, Arsanious A, Plotkin A, Girgis AH, Streutker CJ, Yousef GM.

Hum Pathol. 2012 Jul;43(7):1037-43. doi: 10.1016/j.humpath.2011.08.012. Epub 2011 Dec 26.

PMID:
22204709
50.

Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study.

Iakovlev VV, Gabril M, Dubinski W, Scorilas A, Youssef YM, Faragalla H, Kovacs K, Rotondo F, Metias S, Arsanious A, Plotkin A, Girgis AH, Streutker CJ, Yousef GM.

Lab Invest. 2012 Jan;92(1):46-56. doi: 10.1038/labinvest.2011.153. Epub 2011 Oct 31.

Supplemental Content

Loading ...
Support Center